As on Thursday, Alx Oncology Holdings Inc (NASDAQ: ALXO) started slowly as it slid -0.75% to $1.33, before settling in for the price of $1.34 at the close. Taking a more long-term approach, ALXO posted a 52-week range of $1.29-$17.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -8.67%. Meanwhile, its Annual Earning per share during the time was -50.98%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 25.36%. This publicly-traded company’s shares outstanding now amounts to $49.95 million, simultaneously with a float of $30.26 million. The organization now has a market capitalization sitting at $70.15 million. At the time of writing, stock’s 50-day Moving Average stood at $1.7029, while the 200-day Moving Average is $8.1265.
Alx Oncology Holdings Inc (ALXO) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Alx Oncology Holdings Inc’s current insider ownership accounts for 42.64%, in contrast to 67.13% institutional ownership. According to the most recent insider trade that took place on Aug 14 ’24, this organization’s SVP, FINANCE AND CAO sold 564 shares at the rate of 2.58, making the entire transaction reach 1,455 in total value, affecting insider ownership by 91,549. Preceding that transaction, on Aug 14 ’24, Company’s CHIEF MEDICAL OFFICER sold 1,365 for 2.58, making the whole transaction’s value amount to 3,522. This particular insider is now the holder of 325,711 in total.
Alx Oncology Holdings Inc (ALXO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.82 per share during the current fiscal year.
Alx Oncology Holdings Inc’s EPS increase for this current 12-month fiscal period is 25.36% and is forecasted to reach -2.50 in the upcoming year.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators
Let’s observe the current performance indicators for Alx Oncology Holdings Inc (ALXO). It’s Quick Ratio in the last reported quarter now stands at 4.82. The Stock has managed to achieve an average true range (ATR) of 0.13.
In the same vein, ALXO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.98, a figure that is expected to reach -0.68 in the next quarter, and analysts are predicting that it will be -2.50 at the market close of one year from today.
Technical Analysis of Alx Oncology Holdings Inc (ALXO)
Through scrutinizing the latest numbers posted by the [Alx Oncology Holdings Inc, ALXO], it can be observed that its last 5-days Average volume of 1.01 million was better the volume of 0.78 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 8.53% While, its Average True Range was 0.1211.
Raw Stochastic average of Alx Oncology Holdings Inc (ALXO) in the period of the previous 100 days is set at 0.47%, which indicates a major fall in contrast to 10.45% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 53.65% that was lower than 118.35% volatility it exhibited in the past 100-days period.
